Evidence map›Paper›PMID 38002076›Full record

ArticleBiomedicines2023

Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions.

Nada Lukkahatai, Jongmin Park, Hejingzi Monica Jia, Daniel Martin, Junxin Li, Jennifer Yeong-Shin Sheng, Jessica Gill, Leorey N Saligan, Vered Stearns, Michael Carducci

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Nada LukkahataiSchool of Nursing, Johns Hopkins University, Baltimore, MD 21205, USA.
Jongmin ParkCollege of Nursing, Research Institute of Nursing Science, Pusan National University, Yangsan-si 50612, Republic of Korea.ORCID 0000-0001-6176-5670
Hejingzi Monica JiaBloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Daniel MartinSchool of Nursing, Johns Hopkins University, Baltimore, MD 21205, USA.
Junxin LiSchool of Nursing, Johns Hopkins University, Baltimore, MD 21205, USA.
Jennifer Yeong-Shin ShengJohns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21205, USA.ORCID 0000-0002-4513-4235
Jessica GillSchool of Nursing, Johns Hopkins University, Baltimore, MD 21205, USA.
Leorey N SaliganNational Institute of Nursing Research, National Institutes of Health, Bethesda, MD 20892, USA.
Vered StearnsSchool of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Michael CarducciSchool of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.ORCID 0000-0002-7908-1215
Johns Hopkins University · USNational Institutes of Health · USPusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to examine the feasibility of DNA methylation age as a biomarker for symptoms and resilience in cancer survivors with multiple chronic conditions (MCCs). We included ten participants from our parent study, an ongoing randomized control trial study. Participants' symptoms and resilience were assessed, and peripheral blood was collected. DNA methylation age calculation was performed using DNAge

Indexed as

biomarkerscancer survivorDNA methylation ageresiliencesymptom

Identifiers

PMID38002076
PMCPMC10669866
OpenAlexW4388734435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.